Who are Sodium 5mEq/kg/day's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Sterile Potassium Chloride Concentrate, Magnesium sulphate intramuscular, Magnesium sulfate IV, IV Magnesium Sulfate, Magnesium sulfate 33% solution, Magnesium Sulfate Infusion.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-5meq-kg-day.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Sodium 5mEq/kg/day — Competitive Intelligence Brief

Sodium 5mEq/kg/day (Sodium 5mEq/kg/day) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte supplement. Area: Electrolyte/Metabolic disorders.

marketed Electrolyte supplement Electrolyte/Metabolic disorders Small molecule Live · refreshed every 30 min

Target snapshot

Sodium 5mEq/kg/day (Sodium 5mEq/kg/day) — Hospital del Niño "Dr. Federico Gomez Santos". Sodium supplementation replaces or maintains serum sodium levels to correct hyponatremia or prevent sodium depletion.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Sodium 5mEq/kg/day TARGET	Sodium 5mEq/kg/day	Hospital del Niño "Dr. Federico Gomez Santos"	marketed	Electrolyte supplement
Sterile Potassium Chloride Concentrate	Sterile Potassium Chloride Concentrate	The Queen Elizabeth Hospital	marketed	Electrolyte supplement / Potassium salt	Potassium ion (K+) / Na+/K+-ATPase pump
Magnesium sulphate intramuscular	Magnesium sulphate intramuscular	Nishtar Medical University	marketed	Anticonvulsant; electrolyte supplement	NMDA receptor; voltage-gated calcium channels
Magnesium sulfate IV	Magnesium sulfate IV	University of Liege	marketed	Electrolyte supplement / anticonvulsant	NMDA receptor, L-type calcium channels
IV Magnesium Sulfate	IV Magnesium Sulfate	University Hospitals Cleveland Medical Center	marketed	Electrolyte supplement / anticonvulsant	NMDA receptor antagonist; calcium channel blocker (non-selective)
Magnesium sulfate 33% solution	Magnesium sulfate 33% solution	The Baruch Padeh Medical Center, Poriya	marketed	Electrolyte supplement / anticonvulsant	Voltage-gated calcium channels, NMDA receptors
Magnesium Sulfate Infusion	Magnesium Sulfate Infusion	Ondokuz Mayıs University	marketed	Electrolyte supplement / anticonvulsant / tocolytic agent	NMDA receptor antagonist; calcium channel modulator

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte supplement class)

Hospital del Niño "Dr. Federico Gomez Santos" · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sodium 5mEq/kg/day — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-5meq-kg-day. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab